Missouri Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 20 (71% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 3,318
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 23.49%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 382
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 20.58%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 67.06% 71.73%
White, Hispanic/Latino Patients 2.14% 0.79%
Black/African American, Non-Hispanic/Latino Patients 14.17% 16.23%
Black/African American, Hispanic/Latino Patients 0.36% 0.00%
Asian Patients3 0.90% 0.26%
American Indian/Alaska Native Patients3 0.24% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.09% 0.00%
Patients with More than one race3 1.15% 0.79%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.54% 0.52%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.95% 1.57%
Unreported/Refused to Report Race and Ethnicity 9.40% 8.12%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,190
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 65.58%
COVID-19 Immunization Series Completed 1,127
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 53.38%
COVID-19 Immunization Series Additional 785
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 56.88%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 25.63% 26.35% 17.58%
White, Hispanic/Latino Patients 7.65% 3.46% 1.91%
Black/African American, Non-Hispanic/Latino Patients 34.62% 23.51% 12.99%
Black/African American, Hispanic/Latino Patients 1.01% 0.00% 0.13%
Asian Patients3 1.93% 0.18% 1.15%
American Indian/Alaska Native Patients3 0.50% 0.18% 5.73%
Native Hawaiian/Other Pacific Islander Patients3 0.17% 0.53% 0.13%
Patients with More than one race3 0.50% 0.44% 0.64%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.44% 1.86% 0.51%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.84% 0.98% 0.38%
Unreported/Refused to Report Race and Ethnicity 24.71% 42.50% 58.85%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 40.00%
1 to 24 Hours 25.00%
More Than 24 Hours 35.00%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 40.00%
Vaccine confidence 50.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 10.00%
None 20.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 0.00%
Average Percent of Health Center Visits Conducted Virtually 17.25%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 30.00%
Number of Mobile Van Sites 18
Number of Pop-up Clinics 21
Number of School-Based Vaccination Sites 2

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 5.00%
Refer patients to another organization that provides monoclonal antibody therapies 45.00%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 5.00%
Patient awareness/education 5.00%
Staffing capacity 25.00%
Therapy administration/onsite logistics 30.00%
Other 10.00%
None 50.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021